These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 17283003

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
    Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T.
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
    [Abstract] [Full Text] [Related]

  • 24. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 25. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A, Trinquart L, Marijon E, Lavergne T, Waintraub X, Lepillier A, Chatellier G, Le Heuzey JY, EVADEF investigators.
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biventricular pacing in patients with ICD: how many patients are possible candidates?
    Werling C, Weisse U, Siemon G, Kiessling AH, Rameken M, Schwacke H, Saggau W, Senges J, Seidl K.
    Thorac Cardiovasc Surg; 2002 Apr; 50(2):67-70. PubMed ID: 11981703
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ.
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [Abstract] [Full Text] [Related]

  • 33. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP, Al-Khatib SM, Myers ER, Anstrom KJ, Buxton AE, Peterson ED, Sanders GD.
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ, Spirito P.
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.
    N Engl J Med; 2005 Jan 20; 352(3):225-37. PubMed ID: 15659722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.